. may 16, 2018
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
http://lm360.us/Behn-father-of-Zarriello-from-Laurencekirk?Maceyakmo=176
.
bi accounts
-
.